4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-015324
Chief Technical Officer sold 1,228 shares at $57.22 ($70,266)
- Chief Technical Officer acquired 4,125 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-02-16 | Option exercise 10b5-1 | +4,125 | 9,737 | D | ||
| Shulman Joseph Chief Technical Officer | 2025-02-19 | Sale 10b5-1 | −1,228 | $57.22 | $70,266 | 8,509 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2025-02-14 | Grant or award · Restricted Stock Units 10b5-1 | +25,000 | 25,000 | D | ||
| Shulman Joseph Chief Technical Officer | 2025-02-14 | Grant or award · Stock Options (Right to Buy) 10b5-1 | +37,500 | 37,500 | D | ||
| Shulman Joseph Chief Technical Officer | 2025-02-16 | Option exercise · Restricted Stock Units 10b5-1 | −4,125 | 12,375 | D | ||
| Open-market sales · 1,228 sh · avg $57.22 · $70,266 | |||||||
Loading xslF345X05/tm257103-7_4seq1.xml…